Navigation Links
Bio Base Europe: Flanders and the Netherlands Cooperate on Biofuels From Genetically Modified Poplars

AMSTERDAM, March 15, 2010 /PRNewswire/ -- Bio Base Europe is making progress in the development of sustainable biofuels. The recent first crop of genetically modified poplars of the Flemish Institute for Biotechnology (VIB) will be modified into bioethanol in a Flemish-Dutch pilot installation.

Bio Base Europe, a joint initiative of Biopark Terneuzen and Ghent Bio-Energy Valley, is a successful collaboration between The Netherlands and Flanders. Bio Base Europe is taking the lead in the development of a sustainable biobased economy in Europe.

Bio Base Europe consists of a pilot plant in Ghent for biobased products and processes on the one hand, and a training center for bio-process operators in Terneuzen on the other hand. Bio Base Europe represents a joint investment of 21 Million Euro and is unique in Europe. It was recently awarded with the European "Sail of Papenburg" cross border award.

The first crop of poplars for second generation bio-ethanol production has now been harvested!

In the pilot plant, scientists develop industrial processes to convert agricultural co-products such as wheat straw, corn cobs and wood into so-called second generation biofuels, bioplastics and other biobased products. For that, Bio Base Europe collaborates with the Flemish Institute for Biotechnology (VIB), renowned for its green biotechnology expertise. Prof. Wout Boerjan has developed genetically modified poplars that produce less lignin, facilitating their conversion into bioethanol. On May 6th, 2009 these poplars were planted for the first time in an open air field trial in Ghent. The first crop of this field trial has now been harvested and will be converted into bioethanol at the Bio Base Europe Pilot Plant. This draws us yet another step closer to the realization of second generation biofuels.

Prof. Wim Soetaert, Director of the Bio Base Europe Pilot Plant: "I am very happy with this new development on the long road towards second generation biofuels. It is not coincidentally the result of a Flemish-Dutch collaboration."

Or meet Prof. Wim Soetaert on Europa's largest Biofuels Congres in Amsterdam ( on Monday 15 March at 2pm in the press room of the RAI Convention Centre, Europaplein 22, NL - 1078 GZ Amsterdam, The Netherlands.

A free press pass can be obtained with Mrs Laura Brownie,

SOURCE Bio Base Europe

Back to top
SOURCE Bio Base Europe
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment
2. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
3. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
4. Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
5. Start of First Fingertip Payment Pilot in the Netherlands
6. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
7. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
8. Misonix Announces New Distribution Agreement for The Netherlands
9. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
10. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
11. Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):